Article
Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
Gynecologic oncology - 1 Oct 2007
Saldivar J Salvador, Lu Karen H, Liang Dong, Gu Jian, Huang Maosheng, Vlastos Anne-Therese, Follen Michele, Wu Xifeng
Abstract excerpt
OBJECTIVE: Platinum-based chemotherapy exerts its cytotoxic effect by forming DNA adducts and subsequently inhibiting DNA replication. Removing platinum DNA adducts requires the nucleotide excision repair (NER) pathway. The xeroderma pigmentosum (XP) complementation group of genes plays an essential role in the NER pathway. We hypothesized that genetic polymorphisms in XP genes may predict clinical response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
